Medication adherence issues in patients treated for COPD

Cited by (406)

Items 201–300 of 406

1. Responsibility for COPD self-management in ethno-cultural communities: the role of patient, family member, care provider and the system
   Iraj M. Poureslami, Jessica Shum, Natalie Cheng, John Mark FitzGerald · 2014 · Diversity & Equality in Health and Care
2. Exploring medicines management by COPD patients and their social networks after hospital discharge
   Ellen Ingrid Schafheutle, Tom Fegan, Darren Mark Ashcroft · 2018 · International Journal of Clinical Pharmacy
3. Adherence to COPD free triple inhaled therapy in the real world: a primary care based study
   Alberto Zucchelli, Davide Liborio Vetrano, Elisa Bianchini, Francesco Paolo Lombardo, Alessio Piraino, Marco Zibellini, Alberto Rícci, Alessandra Marengoni, Francesco Lapi, Claudio Alberto Cricelli · 2020 · The Clinical Respiratory Journal
4. Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating Patients with COPD Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenance Therapy
   Chad Moretz, Ashley L. Cole, George Mu, Benjamin Wu, Amy Guisinger, Yunhao Liu, Beth A. Hahn, Lee Baylis · 2020 · International Journal of COPD
5. Experiences With In-Person and Virtual Health Care Services for People With Chronic Obstructive Pulmonary Disease: Qualitative Study
   Thea Krag, Emma Højgaard Jørgensen, Klaus Phanareth, Lars Kayser · 2023 · JMIR Rehabilitation and Assistive Technologies
6. The impact of indacaterol/glycopyrronium fixed-dose combination versus tiotropium monotherapy on lung function and treatment preference: a randomized crossover study – the FAVOR study
   Péter Kardos, Ina Hagedorn-Peinz · 2017 · International Journal of COPD
7. Modern Bronchoscopic Treatment Options for Patients with Chronic Bronchitis
   Anna Katharina Mayr, Arschang Valipour · 2023 · Journal of Clinical Medicine
8. Cognitive screening in chronic obstructive pulmonary disease: patient’s perspectives
   Rebecca T. Disler, Nicolaos Spiliopoulos, Sally C Inglis, David C. Currow, Patricia Mary Davidson · 2019 · Disability and Rehabilitation
9. Counseling of inhalation medicine perceived by patients and their healthcare providers: insights from North Cyprus
   Onur Gültekin, Abdikarim Mohamed Abdi, Haider Al-Baghdadi, Mustafa Akansoy, Finn Rasmussen, Bilgen Başgut · 2019 · International Journal of Clinical Pharmacy
10. Management of patients during and after exacerbations of chronic obstructive pulmonary disease: the role of primary care physicians
    Barbara P. Yawn · 2011 · International Journal of General Medicine
11. Efficacy of indacaterol on quality of life and pulmonary function in patients with COPD and inhaler device preferences
    Masato Muraki, Takeshi Ohno, Shota Wada, Souichirou Hanada, Hirochiyo Sawaguchi, Yuji Tohda · 2014 · International Journal of COPD
12. Self-Reported Overall Adherence and Correct Inhalation Technique Discordance in Chronic Obstructive Pulmonary Disease Population
    Tereza Hendrychova, Michal Svoboda, Josef Malý, Jiřı́ Vlček, Eva Zimčíková, Tomáš Dvořák, Jaromír Zatloukal, Eva Voláková, Marek Plutinský, Kristián Brat et al. · 2022 · Frontiers in Pharmacology
13. Respiratory questionnaire‐based analysis of awareness of COPD in a large multicenter rural population‐based study in India
    Shital Vishnu Patil, Rajesh Patil, Mukund D. Bhise, Anil Jadhav · 2022 · Chronic Diseases and Translational Medicine
14. Complexity of Medication Use in Newly Diagnosed Chronic Obstructive Pulmonary Disease Patients
    Caitlyn T. Solem, Todd A. Lee, Min J. Joo, Bruce L. Lambert, Surrey M. Walton, Alan Simon Pickard · 2012 · The American Journal of Geriatric Pharmacotherapy
15. Genuair ® in Chronic Obstructive Pulmonary Disease: A Novel, User-Friendly, Multidose, Dry-Powder Inhaler
    Job A.M. van der Palen · 2014 · Therapeutic Delivery
16. ADHERENCE IN PREGNANCY: A SYSTEMATIC REVIEW OF THE LITERATURE
    Mary Oladejo, Susan Bewley · 2012 · Fetal and Maternal Medicine Review
17. Respiratory Medication Adherence: Toward a Common Language and a Shared Vision
    Eric H. Van Ganse, David Brendan Price · 2016 · The Journal of Allergy and Clinical Immunology In Practice
18. Patients with underuse or overuse of inhaled corticosteroids have different perceptions and beliefs regarding COPD and inhaled medication
    Kirsten Koehorst-ter Huurne, Marjolein G J Brusse-Keizer, Paul van der Valk, Kris L. L. Movig, Job A.M. van der Palen, Christina Bode · 2018 · Patient Preference and Adherence
19. Role of risk attitude and time preference in preventive aspirin use adherence
    Jingrong Zhu, Yunfeng Shi, Jinlin Li, Zengbo Zhang · 2019 · Journal of Evaluation in Clinical Practice
20. Asthma and COPD medicines prescription-claims: A time-series analysis of England’s national prescriptions during the COVID-19 pandemic (Jan 2019 to Oct 2020)
    Ravina Barrett, Robert D. Barrett · 2021 · Expert Review of Respiratory Medicine
21. Supporting respiratory patients in primary care: a qualitative insight from independent community pharmacists in London
    Iman Hesso, Reem Kayyali, Shereen Nabhani‐Gebara · 2019 · BMC Health Services Research
22. Educational and supportive interventions for improving adherence to inhalation therapy in people with chronic respiratory diseases: A systematic review protocol
    Ka Wing To, Wai Man Lee, Kai Chow Choi, Doris Sau Fung Yu, Janita Pak Chun Chau, Iris Lee · 2013 · The JBI Database of Systematic Reviews and Implementation Reports
23. “It’s a lonely battle”: A qualitative study of older adult Canadians’ experiences with chronic obstructive pulmonary disease medication adherence and support
    Leanne Skerry, Emily K. Kervin, Tracy A. Freeze, Andrew Brillant, Jennifer Woodland, Natasha E. Hanson · 2022 · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
24. Analysis of use of technological support and information content by patients with chronic obstructive pulmonary disease
    José Miguel Padilha, Paulino Sousa, Filipe Miguel Soares Pereira · 2012 · Acta Paulista de Enfermagem
25. Correct usage, ease of use, and preference of two dry powder inhalers in patients with COPD: analysis of five phase III, randomized trials
    John Riley, Maggie M Tabberer, Nathalie Richard, Alison Donald, Alison Church, Stephanie Schweiker Harris · 2016 · International Journal of COPD
26. Sleep Disorders and Adherence to Inhalation Therapy in Patients with Chronic Obstructive Pulmonary Disease
    Mariusz Chabowski, Judyta Łuczak, Krzysztof D. Dudek, Beata Jankowska‐Polańska · 2019 · Advances in experimental medicine and biology
27. The effect of family-centered care on adherence to treatment in patients with type 2 diabetes
    همتی مسلک پاک, معصومه, علیپور, شهین, آقاخانی, نادر, خلخالی, حمیدرضا · 2020 · مجله علمی دانشگاه علوم پزشکی بیرجند
28. Outcomes Following Initiation of Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol versus Multiple-Inhaler Triple Therapy Among Medicare Advantage with Part D Beneficiaries and Those Commercially Enrolled for Health Care Insurance in the United States
    Michael Bogart, Lindsay G.S. Bengtson, Mary G Johnson, Scott H. Bunner, Noelle N. Gronroos, Kristi DiRocco · 2024 · International Journal of COPD
29. Efficacy and safety of LABA/LAMA fixed-dose combinations approved in the US for the management of COPD
    Donald D. Banerji, Donald A. Mahler, Nicola Alexander Hanania · 2016 · Expert Review of Respiratory Medicine
30. Role of Long-Acting Muscarinic Antagonist/Long-Acting β 2 -Agonist Therapy in Chronic Obstructive Pulmonary Disease
    Sarah E. Petite · 2017 · Annals of Pharmacotherapy
31. Real life profile of asthma and chronic obstructive pulmonary disease patients in Turkey
    Zeynep Mısırlıgil, Arif Hikmet Cimrin, Hakan Günen, Tevfik Özlü, Aykut Çilli, Levent Akyıldız, Hasan Bayram, Bilun Gemicioğlu, Esra Uzaslan, Öznur Abadoğlu et al. · 2017 · Tuberkuloz ve Toraks
32. The Effect of Opioid Use and Mental Illness on Chronic Disease Medication Adherence in Superutilizers
    Satya Surbhi, Ilana Graetz, Jim Y. Wan, Justin D. Gatwood, James E. Bailey · 2018 · Journal of Managed Care & Specialty Pharmacy
33. Clinical features, bacteriology of endotracheal aspirates and treatment outcomes of patients with chronic obstructive pulmonary disease and community-acquired pneumonia in an intensive care unit in Taiwan with an emphasis on eosinophilia versus non-eosinophilia: a retrospective case–control study
    Wei‐Chang Huang, Ching-Hsiao Lee, Ming‐Feng Wu, Chen-Cheng Huang, Cheng-Hui Hsu, Hui‐Chen Chen, Jeng‐Yuan Hsu, Chieh‐Chen Huang · 2018 · BMJ Open
34. Temporary Telemedicine Policy and Chronic Disease Management in South Korea: Retrospective Analysis Using National Claims Data
    Ji Ye Kang, Weon Jung, Hyun Ji Kim, Ji Hyun An, Hee Jo Yoon, Taerim Kim, Hansol Chang, Sung Yeon Hwang, Jong Eun Park, Gun Tak Lee et al. · 2024 · JMIR Public Health and Surveillance
35. Which treatment for obstructive airway disease: The inhaled bronchodilators
    Fabio Perrotta, Filomena Mazzeo, Francesco Saverio Cerqua · 2017 · Pulmonary Pharmacology & Therapeutics
36. Efficacy of an educational intervention in primary health care in inhalation techniques: study protocol for a pragmatic cluster randomised controlled trial
    José Leiva-Fernández, R. Vazquez-Alarcon, Virginia Patricia Aguiar-Leiva, M. Lobnig-Becerra, Francisca Leiva-Fernández, Pilar Barnestein‐Fonseca · 2016 · Trials
37. Demographic, Clinical and Management Characteristics of Newly Diagnosed COPD Patients in Turkey: A Real-Life Study
    Mecit Süerdem, Hakan Günen, Levent Akyıldız, Aykut Çilli, Tevfik Özlü, Esra Uzaslan, Öznur Abadoğlu, Hasan Bayram, Arif Hikmet Cimrin, Bilun Gemicioğlu et al. · 2020 · International Journal of COPD
38. Ten clinical pharmacological interventions in routine care to ensure better treatment outcomes
    Saibal Das, Shambo Samrat Samajdar, Shatavisa Mukherjee, Sougata Sarkar, Sumalya Sen, Ashish Pathak, Cecilia Stålsby Lundborg, Sandhiya Selvarajan, Santanu Kumar Tripathi, Jyotirmoy Pal et al. · 2023 · International Journal of Pharmacy Practice
39. The role of galenic innovation in improving treatment compliance and persistence: three case studies
    York Francis Zöllner, Balp, Andrea Gili Marco · 2011 · ClinicoEconomics and Outcomes Research
40. Strategies used by respiratory nurses to stimulate self‐management in patients with COPD
    Remco Verbrugge, Fijgje de Boer, Jean‐Jacques Georges · 2013 · Journal of Clinical Nursing
41. Readmission Risk in Chronic Obstructive Pulmonary Disease Patients: Comparative Study of Nebulized β2-Agonists
    Vamsi K. Bollu, Annie Guérin, Geneviève Gauthier, Robert Hiscock, Eric Qiong Wu · 2016 · Drugs - Real World Outcomes
42. Choosing the right inhaler for the right patient: Considerations for effective management of patients with chronic obstructive pulmonary disease or asthma
    Haley M. Hoy, Louise C. O’Keefe · 2020 · Journal of the American Association of Nurse Practitioners
43. ABC of COPD
    Graeme P. Currie · 2011
44. Real-world outcomes in patients with chronic obstructive pulmonary disease initiating long-acting mono bronchodilator therapy
    Lindsay G.S. Bengtson, Michael R. DePietro, Jeffrey McPheeters, Kathleen M. Fox · 2018 · Therapeutic Advances in Respiratory Disease
45. Impact of medication adherence on emergency department visits in patients with COPD in a single tertiary hospital in Saudi Arabia
    Alshehri, Samah, Alshibani, Mohannad · 2023 · International Journal of Chronic Obstructive Pulmonary Disease
46. Symptom Burden and GOLD Classification in Medicare Advantage Patients with COPD Initiating Umeclidinium/Vilanterol or Fluticasone Propionate/Salmeterol Therapy
    Chad Moretz, Beth A. Hahn, John C. White, Alyssa Goolsby Hunter, Breanna Essoi, Caitlin Elliott, Riju Ray · 2020 · International Journal of COPD
47. Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD)
    Sadia Janjua, Katharine C. Pike, Robin Carr, Andy Coles, Rebecca Fortescue · 2019 · Cochrane Database of Systematic Reviews
48. Inhaled Corticosteroid Withdrawal and Change in Lung Function in Primary Care Patients with Chronic Obstructive Pulmonary Disease in England
    Hannah R. Whittaker, Kevin Wing, Ian Douglas, Steven John Kiddle, Jennifer Kathleen Quint · 2022 · Annals of the American Thoracic Society
49. Decreasing Hospital Readmissions Utilizing an Evidence-Based COPD Care Bundle
    Moira Kendra, Rupal Patel Mansukhani, Nicole Rudawsky, Lisa Landry, Natalie Reyes, Stephanie H. Chiu, Brittney Daley, Daniel Markley, Brandee Fetherman, Edward A. Dimitry et al. · 2022 · Lung
50. Evaluation and importance of different types of inhaler device in patients with chronic obstructive lung disease
    Can Öztürk, Yağmur Aldağ, Nilgün Yılmaz Demirci · 2017 · Tuberkuloz ve Toraks
51. Objective Assessment of Adherence to Inhalers by COPD Patients
    Sulaiman, Imran, Cushen, Breda, Greene, Garrett, Seheult, Jansen, Seow, Dexter, Rawat, Fiona, MacHale, Elaine, Mokoka, Matshediso, Moran, Catherine Nora, Bhreathnach, Aoife Sartini et al. · 2019 · Case Medical Research
52. Determination of the psychometric properties of the Patients’ Self-Efficacy Scale in blood pressure patients
    Raheleh Ghadiri, Masoumeh Alimohammadi, Hesamedin Askari Majdabadi · 2018 · Interventional Medicine and Applied Science
53. Impact on survival of combination inhalers in patients with COPD at high risk of cardiovascular events
    Hitesh C. Patel, Carl Hayward, Ketna Patel, Brian Lee Claggett, Ali Vazir, Martín Cowie · 2019 · International Journal of Cardiology
54. Recruiting people facing social disadvantage: the experience of the Free Meds study
    Pauline Norris, Kimberly Cousins, Kimberly Cousins, Marianna Churchward, Marianna Churchward, Shirley Keown, Shirley Keown, Mariana Hudson, Mariana Hudson, Leina Isno et al. · 2021 · International Journal for Equity in Health
55. Adjunctive treatment with oral AKL1, a botanical nutraceutical, in chronic obstructive pulmonary disease
    Andrew M. Wilson, Claire Brockwell, Sundari Ampikaipakan, Darren W. Sexton, David Price, Daryl Freeman, Mike D. Thomas, Muzammil Ali · 2014 · International Journal of COPD
56. Adherence to preventive medications in asthmatic children at a tertiary care teaching hospital in Malaysia
    Noraida Mohamed Shah, Adyani Md Redzuan, Meng Soon Lee · 2014 · Patient Preference and Adherence
57. AIMAR survey on COPD phenotypes
    Maria Sandra Magnoni, Andrea Rizzi, Alberto Visconti, Claudio Ferdinando Donner · 2014 · Multidisciplinary Respiratory Medicine
58. Impact of Therapy Persistence on Exacerbations and Resource Use in Patients Who Initiated COPD Therapy
    Faustine Dalon, Gilles Devouassoux, Manon Belhassen, Gaëlle Nachbaur, Camille Correia Da Silva, Lynda Sail, Flore Jacoud, CHRISTOS CHOUAID, Eric H. Van Ganse · 2019 · International Journal of COPD
59. Chinese Medicine for Chronic Obstructive Pulmonary Disease: A Pilot Study on Patient Preferences
    Shaonan Liu, Jiaqi Lai, Lei Wu, Xinfeng Guo · 2021 · Patient Preference and Adherence
60. Patient preference for a maintenance inhaler in chronic obstructive pulmonary disease: a comparison of Breezhaler and Respimat
    Philip O’Hagan, Juergen Dederichs, Boomi Viswanad, Μatthias Gasser, Susann Walda · 2018 · Journal of Thoracic Disease
61. Narrative Review of the Role of Patient-Reported Outcomes and Inhaler Handling Errors in the Control of Asthma and COPD
    R. de Simón Gutiérrez, Raúl Piedra Castro · 2022 · Current Allergy and Asthma Reports
62. Long-Acting Bronchodilator Use in Chronic Obstructive Pulmonary Disease in Primary Care in New Zealand: A Retrospective Study of Treatment Patterns and Evolution Using the HealthStat Database
    Dominique Milea, See‐Hwee Yeo, Yein Nam, Aldo Amador Navarro Rojas, Sumitra Shantakumar, Janine Beale, Brett Marett, Robert P. Young, Raewyn J. Scott, Barry Gribben · 2021 · International Journal of COPD
63. Adherence to Long-Acting Inhaler Use for Initial Treatment and Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study
    Hee-Sook Suh, Min-Seok Chang, Iseul Yu, Sunmin Park, Ji-Ho Lee, Seok Jeong Lee, Won‐Yeon Lee, Suk Joong Yong, Sang‐Ha Kim · 2022 · Journal of Personalized Medicine
64. Real-World Use of Inhaled COPD Medications: the Good, the Bad, the Ugly
    Valerie G. Press · 2024 · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation
65. Reduced Cost Sharing and Medication Management Services for COPD
    Sumit D. Agarwal, Elizabeth Metzler, Michael E. Chernew, Emily Thomas, Valerie G. Press, Emily C. Boudreau, Brian W. Powers, J. Michael McWilliams · 2024 · JAMA Internal Medicine
66. The use of COPD maintenance therapy following spirometry in General Practice
    Vibeke Gottlieb, Anne Marie Lyngsø, Ditte Sæbye, Anne Frølich, Vibeke Backer · 2016 · European Clinical Respiratory Journal
67. Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax® compared with Turbuhaler® in patients with moderate-to-severe chronic obstructive pulmonary disease in Spain
    Josep Darbà, Gabriela Ramírez, Juan Luis Garcia Rivero, Sagrario Mayoralas-Alises, José Francisco Pascual-Lledó, Diego Vargas, Adi Bijedic · 2017 · ClinicoEconomics and Outcomes Research
68. Patient perception of Breezhaler® and Ellipta® device feedback mechanisms in COPD: The ADVANTAGE Study
    Pablo Altman, Miguel Angel Bergna, Gabriel R. Garcia, Tadhg Guerin, Andrea Pino, John L. Whiteford · 2018 · Current Medical Research and Opinion
69. Computer-Mediated Experiences of Patients With Chronic Obstructive Pulmonary Disease
    Samantha R. Paige, Michael Stellefson, Janice L. Raup Krieger, Julia M. Alber · 2019 · American Journal of Health Education
70. Understanding Practice Patterns of COPD: A Survey of Physicians in Nepal, Sri Lanka and Malaysia
    Ramesh Chokhani, Abdul Razak Muttalif, Kirthi Gunasekera, Aniruddha Mukhopadhyay, Vaibhav Gaur, Jaideep A. Gogtay · 2021 · Pulmonary Therapy
71. Factors associated with medication adherence among people living with COPD: Pharmacists' perspectives
    Bimbishar Bhattarai, Ramesh Lahiru Walpola, Sohil Ahmed Khan, Amary Mey · 2021 · Exploratory Research in Clinical and Social Pharmacy
72. Pharmacist involvement in the inhaler choice improves lung function in patients with COPD: a prospective single-arm study
    Eiji Shiwaku, Satoshi Dote, Shinobu Kaneko, Chisato Hei, Masaki Aikawa, Yuki Sakai, Takahiro Kawai, Shigeaki Iwatsubo, Michinobu Hashimoto, Teppei Tsuneishi et al. · 2021 · Journal of Pharmaceutical Health Care and Sciences
73. Targeting exertional breathlessness to improve physical activity: the role of primary care
    Miguel Román-Rodríguez, Janwillem W.H. Kocks · 2021 · npj Primary Care Respiratory Medicine
74. Can ENDS technology facilitate the delivery of medicines?
    Federico Buonocore, Stephen Barton, Shereen Nabhani‐Gebara, G. Calabrese · 2023 · Journal of Drug Delivery Science and Technology
75. A single home visit improves adherence and reduces healthcare utilization in patients with frequent exacerbations of Severe Asthma and COPD
    Anil Ghimire, Richard Allison, Yunuen Lichtemberg, Jose Joseph Vempilly, Vipul V. Jain · 2021 · Respiratory Medicine X
76. Adherence to Therapy in Chronic Obstructive Pulmonary Disease
    Tamás Ágh, Ágnes Mészáros · 2012 · InTech eBooks
77. Medication adherence in chronic obstructive pulmonary disease
    Debbie Duncan · 2015 · Practice Nursing
78. COPD-treating nurses’ preferences for inhaler attributes – a discrete choice experiment
    Mette Bøgelund, Lise Meinicke Hagelund, Mikael Bergholdt Asmussen · 2016 · Current Medical Research and Opinion
79. Pathology-informed telemedicine in COPD care: A qualitative study on patient perspectives and medication adherence
    Rehab Jameel Alharbi, Asmaa Khalaf Alshammari · 2025 · Journal Of Advanced Pharmacy Education And Research
80. DuoResp® Spiromax® adherence, satisfaction and ease of use: findings from a multi-country observational study in patients with asthma and COPD in Europe (SPRINT)
    Job A.M. van der Palen, Isa Cerveri, Nicolás Roche, Dave Singh, Vicente Plaza, Chelo Gonzalez, Oliver Patino, Irma Scheepstra, GUILHERME G SAFIOTI, Vibeke Backer · 2019 · Journal of Asthma
81. Validation of a sensitive and specific LC–MS/MS method and application to evaluate the systemic exposure and bioavailability of glycopyrrolate via different drug delivery approaches/devices
    Lei Shi, Armand G. Ngounou Wetie, Weimin Wang, Yu‐Luan Chen · 2020 · Biomedical Chromatography
82. Factors Associated with Non-Adherence to Self-Management Among Patients with Chronic Obstructive Pulmonary Disease: A Survey Using the Delphi Technique and Analytic Hierarchy Process
    Ja-Yun Choi, E. Ryu · 2024 · International Journal of COPD
83. Significance of Medication History at the Time of Entry into the COPDGene Study: Relationship with Exacerbation and CT Metrics
    Seoung Ju Park, Barry J. Make, Craig P. Hersh, Russell Paul Bowler · 2014 · COPD Journal of Chronic Obstructive Pulmonary Disease
84. Readability and Suitability of COPD Consumer Information
    Kathryn Fullmann, David F Blackburn, Mark E. Fenton, Holly Mansell · 2017 · Canadian Respiratory Journal
85. Stem cells therapy: a review on approaches that can be used for treatment of respiratory failures in sulfur mustard-injured patients
    Amir Nejad-Moghaddam, Eisa Tahmasbpour, Milad Sohrabiyan, Hossein Jafari, Mostafa Ghanei · 2018 · Immunopharmacology and Immunotoxicology
86. Comparative Causal Analysis of the Effects of Long-Acting Muscarinic Antagonist Versus No Long-Acting Bronchodilator Use on Readmission or Mortality After Hospitalization for Chronic Obstructive Pulmonary Disease
    Melissa H. Roberts, Douglas W. Mapel, Hans V. Petersen · 2019 · Drugs - Real World Outcomes
87. ICS/Ultra LABA in the Treatment of Obstructive Airway Diseases: A Consensus of Indian Experts
    Raja Dhar, Deepak Talwar, Prince James, Ashwini Kumar Mishra, Judo Vachaparambil, Saiprasad Patil, Nishtha Khatri, Sagar Bhimrao Bhagat, Hanmant V. Barkate · 2022 · Advances in respiratory medicine
88. Trends of Chronic Obstructive Pulmonary Disease Diagnosis and Treatment in Rural Setting in India
    Shital Vishnu Patil, Gajanan Gondhali, Manojkumar Bhadake, Anil Jadhav · 2022 · Journal of Association of Pulmonologist of Tamil Nadu
89. Pharmacologic rationale, efficacy and safety of the fixed-dose co-formulation of indacaterol and glycopyrronium
    Girolamo Pelaia, Rosario Maselli, Luca Gallelli · 2014 · Multidisciplinary Respiratory Medicine
90. Real-world mapping of allergy immunotherapy in the United States: The argument for improving adherence
    Brian D. Stone, Karen S. Rance, Douglas Waddell, Mark Aagren, Eva Hammerby, Joseph P. Tkacz · 2020 · Allergy and Asthma Proceedings
91. Development of a graphical tool to measure medication adherence in asthma patients: A mixed-methods pilot study
    Alia Yousif, Catherine Lemière, André Cartier, Amélie Forget, Lucie Blais · 2018 · Journal of Asthma
92. Patient and Health Care Provider Perspectives on Potential Preventability of Hospital Admission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Qualitative Study
    Anna Leenders, Esther T. Sportel, E Poppink, Wendy van Beurden, Paul van der Valk, Marjolein G J Brusse-Keizer · 2022 · Patient Preference and Adherence
93. Access to Treatment for Chronic Obstructive Pulmonary Disease in the Americas: A Call for Action. A Joint Perspective from the Brazilian Thoracic Society, Canadian Thoracic Society, Latin American Thoracic Society, and the American Thoracic Society
    Francesca Polverino, Mohit Bhutani, Gustavo Enrique Zabert, Frederico Leon Arrabal Fernandes, KAREN CZISCHKE L, Luiz Fernando Pereira Ferreira, Lian Szabo, Juan P. Wisnivesky, Margareth Pretti Dalcolmo, Juan Carlos Celedon · 2024 · Annals of the American Thoracic Society
94. Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD
    Juliet Rebello, A Bhattacharya, Salil Bhargava, Virendra Kumar Singh, Deepak Talwar, Jagdeep Whig, Shrinivas Purandare, Jaideep A. Gogtay · 2016 · International Journal of COPD
95. Concordance between reported medication taking behavior and prescription instructions for patients with chronic obstructive pulmonary disease visiting community pharmacies
    Theresa R. Prosser, Suzanne G. Bollmeier · 2022 · Journal of the American Pharmacists Association
96. Code-Switching in Selling and Buying at Segiri Market Samarinda, East Kalimantan: a Sociolinguistics Study
    Islamiah Bastiar, Sri Marmanto, Sumarlam Sumarlam · 2018 · Lingua Cultura
97. Incentive-driven post-discharge compliance management for chronic disease patients in healthcare service operations
    Aditya Mahadev Prakash, Qiao‐Chu He, Xiang Zhong · 2019 · IISE Transactions on Healthcare Systems Engineering
98. Wpływ doboru inhalatora i cząstki na skuteczność terapii wziewnej w POChP
    Paweł Śliwiński, Ryszarda Chazan, Piotr Dąbrowiecki, Karina Jahnz‐Różyk, Robert Marek Mróz, Michał Pirożyński · 2014 · Advances in respiratory medicine
99. Wie praxisrelevant sind die GOLD-Empfehlungen für den ambulanten Alltag bei COPD?
    Björn Laudahn, Sören Schmidtmann · 2015 · Pneumo News
100. NEW FIXED COMBINATION OF LONG-ACTING ANTICHOLINERGIC GLYCOPYRRONIUM BROMIDE AND β2-AGONIST OF INDACATEROL: PROSPECTS OF COBD THERAPY
     Sergey Nikolaevich Avdeev · 2016 · Meditsinskiy sovet = Medical Council